TSMC October 2026 revenue
NT$586.9B
Up 59.7% year on year; monthly revenue report, Nov 10, 2026
Q4 2026 revenue guidance
$52.3–54.3B
Set Oct 15, 2026; needs about $17.7B a month in Nov–Dec
TSMC 2026 capital spending
$60–64B
Reiterated with Q3 results, Oct 15, 2026; no 2027 figure given
Oracle capex, trailing 12 months
$75.7B
vs $46.9B operating cash flow; Form 10-Q, quarter ended Aug 31, 2026
CoreWeave capex, trailing 12 months
$20.6B
vs $6.9B operating cash flow; Form 10-Q, quarter ended Jun 30, 2026
Micron gross margin, FQ4 2026
86.8%
vs 66.4% gross margin at TSMC in 3Q 2026
The print
October Confirms the Schedule; It Does Not Raise the Bar
The most useful thing about TSMC's October number is what it does not tell you. Revenue of NT$586.89 billion ($17.88 billion) was 59.7% above a year earlier and 14.7% above September — and it landed almost exactly on the pace the company had already promised. Fourth-quarter guidance of $52.3–54.3 billion, set on October 15, requires roughly $17.7 billion a month in November and December. A record month that only just clears the bar management set for itself confirms a production schedule rather than resetting expectations.
TSMC's revenue is a scheduled ramp, not a step change
Dollar revenue by quarter. First two quarters converted at TSMC's stated quarterly exchange-rate assumptions; third quarter actual and fourth-quarter guidance as reported with the Q3 2026 results on Oct 15, 2026.
Unit: US$ billions
1Q 2026
NT$1,134.1B reported
35.5
2Q 2026
NT$1,270.4B reported
40.2
3Q 2026
Actual, +41.2% year on year
46.7
4Q 2026 guide
Midpoint of $52.3–54.3B
53.3
- Confirms the 2nm ramp: 2-nanometer reached 8% of wafer revenue in 3Q26, and N2 family annual capacity is expected to more than double in 2027.
- Leaves the bar unchanged: October's $17.88B already sits inside the $52.3–54.3B fourth-quarter guide, so a November run-rate below $17.7B breaks the schedule, not the demand story.
- Moves the 2027 debate onto financing: management was explicit that it is being prudent in planning for 2027 and declined to give a 2027 revenue or capital spending number.
- Confirms packaging as the pacing item: the CoWoS supply-demand gap narrows from 20% to 10% by end-2026 as capacity expands, so allocation still decides what ships.
The schedule
The Order Book Was Written Before the Money Arrived
TSMC's 2026 capital program of $60–64 billion, plus management's statement that spending across 2026 to 2028 will be significantly higher than in the previous three years, is the real order book. Suppliers are being asked to commit capacity years ahead: ASML says supply planned for 2027 and 2028 will not fully meet demand and that some customers are already discussing 2029 and 2030 orders, while Applied Materials guided to a record $10.25 billion fourth quarter on DRAM, leading-edge foundry-logic and advanced packaging demand. That is what a schedule looks like when it describes a production plan written years ahead of the revenue it produces.
| Layer | Latest reported | Next checkpoint |
|---|---|---|
| Foundry — TSMC | 3Q26 revenue $46.72B; gross margin 66.4%; 2nm 8% of wafer revenue | 4Q26 guide $52.3–54.3B; N2 annual capacity to more than double in 2027 |
| Lithography — ASML | 3Q26 net sales €11.7B; gross margin 57.5%; FY2026 guide €44–45B | 2027–28 supply will not fully meet demand; 2028 capacity add under review |
| Deposition, etch and packaging — Applied Materials | 3Q FY26 revenue $9.12B (+25%); DRAM 26% of systems mix, up from 22% | 4Q FY26 guide $10.25B, plus or minus $0.5B |
| Memory — Micron | FQ4-26 revenue $54.23B; gross margin 86.8%; FQ1-27 guide $61.5B | Most of calendar 2027 HBM bit supply contracted at higher prices |
| Memory — SK hynix | 3Q26 revenue KRW 104.6tn; operating profit KRW 83.3tn | HBM4 set to pass HBM3E in both volume and revenue in 4Q26 |
| Advanced packaging | CoWoS supply-demand gap narrowing from 20% to 10% by end-2026 (TrendForce) | 5x reticle in production; 9x and 14x reticle packages in development |
- Equipment, not wafer demand, is the tight link: ASML is already investigating a 2028 capacity increase beyond the 30% previously communicated.
- Packaging gaps are closing but not closed: a 10% CoWoS shortfall at end-2026 still means AI packages queue behind wafer starts.
- Dilution is now geographic: overseas fabs are expected to widen margin drag to 3–4 points over the next few years, with another 40 basis points guided out in 4Q26.
The funding chain
Where the Money Sits: Four Balance Sheets Carry the Wafers
This is the part a monthly revenue number cannot show. The buyers whose demand fills TSMC's schedule are funding it with debt and equity raised in the very quarters the wafers ship. Oracle spent $75.7 billion on property and equipment in the trailing twelve months to Aug 31, 2026 against $46.9 billion of operating cash flow, funding the $28.7 billion gap with $37.2 billion of net new debt and $25.1 billion of net new equity. CoreWeave spent $20.6 billion against $6.9 billion of operating cash flow, funding its $13.7 billion gap with $16.8 billion of net debt issuance and $5.8 billion of stock issuance. Above them sit OpenAI, which closed a $122 billion funding round at an $852 billion post-money valuation on March 31, 2026, and SoftBank Group, which has put $64.6 billion into that company. A revenue line turns an order book into a funding question.
| Node in the chain | How the build is funded | Latest reported numbers | Implication for wafer demand |
|---|---|---|---|
| OpenAI (private) | Equity capital plus an undrawn $4.7B revolving credit facility | $122B committed capital at an $852B post-money valuation (Mar 31, 2026) | Demand is real but concentrated on one private balance sheet |
| SoftBank Group | Foreign-currency senior notes issued Sep 24, 2026; $40B bridge facility repaid and cancelled | $64.6B cumulative OpenAI investment for about 13% (Oct 1, 2026) | The chain's largest single financier is now a bond issuer |
| Oracle | $43B of debt and $5B of equity raised in FY2026; $20B of ATM equity sold in 1Q FY27 | Trailing capex $75.7B vs $46.9B operating cash flow; net debt $119.6B at Aug 31, 2026 | A $664B backlog funded with balance-sheet capacity, not earnings |
| CoreWeave | $16.8B of net debt issuance and $5.8B of stock issuance over four quarters | Trailing capex $20.6B; trailing interest expense $1.87B; 2Q26 operating loss $49M | Debt-funded capacity is the most fragile node in the chain |
Oracle's interest bill is outrunning its revenue growth
Quarterly interest expense. Revenue rose 30% year on year in the September 2026 quarter while interest expense rose 55% (Oracle Form 10-Q, quarter ended Aug 31, 2026).
Unit: US$ billions
1Q FY26
Quarter ended Aug 31, 2025
0.9
2Q FY26
Quarter ended Nov 30, 2025
1.1
3Q FY26
Quarter ended Feb 28, 2026
1.2
4Q FY26
Quarter ended May 31, 2026
1.4
1Q FY27
Quarter ended Aug 31, 2026
1.4
- Converts backlog into a funding requirement: Oracle's remaining performance obligations reached $664B, yet management says newly structured contracts add no relief to its capital-raising plans — each new dollar of AI demand adds funding, not headroom.
- Converts contracts into hardware: Oracle delivered more than 300,000 GPUs to AI Cloud customers after the June quarter and nearly tripled delivered capacity versus 4Q FY26, so the backlog is being built, not merely booked.
- Leaves the neocloud model thin: CoreWeave's trailing interest expense of $1.87B equals 25% of its $7.59B of trailing revenue, with no operating profit to cover it.
The market's verdict
The Chain Is Traded on Funding, Not on Wafers
The tell is what the market did with these numbers. Every link in the chain trades far below its 52-week high even as revenue records stack up: CoreWeave sits 65% below its high, SoftBank Group 63%, Oracle 54%, Micron 42%, ASML 24%. The biggest buyers at the top of the chain — the four largest US hyperscalers, heading toward roughly $760 billion of 2026 capital spending — fund that spending largely from operating cash flow. The marginal buyers do not. A tape that shrugged off a record October print is pricing funding rather than wafers.
| Company | Last close | 52-week high | Below high |
|---|---|---|---|
| CoreWeave | US$48.98 | US$138.25 | -65% |
| SoftBank Group | ¥3,400 | ¥9,074 | -63% |
| Oracle | US$116.10 | US$250.25 | -54% |
| Micron | US$733.15 | US$1,255.00 | -42% |
| ASML | US$1,518.95 | US$1,999.96 | -24% |
Where the margin lives
Pricing Power Sits in Memory; Volume Sits in Wafers
The distinction the monthly print obscures is where the margin actually lives. Micron earned an 86.8% gross margin in its September quarter and has contracted the vast majority of its calendar 2027 HBM bit supply at significantly higher prices. SK hynix turned KRW 104.6 trillion of quarterly revenue into KRW 83.3 trillion of operating profit — roughly an 80% operating margin — and has long-term agreements with 14 customers covering more than half of its 2027 and 2028 capacity. TSMC, which actually makes the wafers, ran a 66.4% gross margin with another 40 basis points guided out in the fourth quarter. Volume shows up in the foundry; pricing power shows up in memory and in the tools that supply it.
Gross margin, most recently reported
Micron and TSMC from their September 2026 quarters; ASML and Applied Materials from their latest reported quarters; CoreWeave on a trailing-twelve-month basis to Jun 30, 2026.
Unit: Gross margin (%)
Micron (FQ4 2026)
Revenue $54.23B
86.8%
TSMC (3Q 2026)
Revenue $46.72B
66.4%
CoreWeave (trailing)
Revenue $7.59B, but operating loss
67.4%
ASML (3Q 2026)
Net sales €11.7B
57.5%
Applied Materials (3Q FY26)
Revenue $9.12B
50.3%
- Makes memory the scarce asset: Micron sees no line of sight to memory supply-demand balance, with industry DRAM bit shipments growing in the mid-20s% in 2026 and low-20s% in 2027 and 2028 on a supply-constrained base.
- Feeds the equipment cycle: DRAM is now 26% of Applied Materials' systems mix, up from 22%, and the company raised calendar 2026 systems expectations on AI-driven demand.
- Sets the ceiling for the foundry: TSMC describes its pricing as strategic by segment, location and technology, while margin is now squeezed by 2nm ramp dilution and a widening overseas mix penalty.
Next 90 days
Near Term: The Next Two Quarters Test the Thesis
- Checks the run-rate rather than the story: TSMC's November revenue release on Dec 10, 2026 has to average about $17.7 billion a month to deliver the fourth-quarter guide.
- Tests whether backlog converts to cash: Oracle's December-quarter report should show whether a $664B order book and the GPU delivery ramp keep pace with $28.5 billion of quarterly capex.
- Tests whether memory pricing is structural: Micron's fiscal first-quarter report must deliver the guided $61.5 billion at roughly 86% gross margin, or the chain's pricing power starts to look cyclical.
- Tests who gets paid first: Applied Materials' $10.25 billion fourth-quarter guide and ASML's €14.2–15.2 billion fourth-quarter guide are the cleanest read on whether capex is still self-funding.
2027–2028
Longer Term: What Has to Be True Through 2028
- Funding has to keep clearing: Oracle expects roughly $70 billion of net capex in fiscal 2027 and has flagged further capital raising, so the chain needs cheap balance sheets, not just orders.
- The bottleneck has to keep moving: N2 capacity more than doubling in 2027 and CoWoS gaps narrowing toward 10% decide how much of the schedule can ship; if packaging stalls, wafer revenue stalls with it.
- Memory pricing has to outrun supply: with industry DRAM bits still growing in the low-20s% in 2027 and 2028 and no line of sight to balance, an 86.8% gross margin is the first thing to crack if supply responds.
- Silence on 2027 is the tell: if TSMC stays guidance-free in its January results, the binding constraint is funding, not demand.
Our business in the third quarter was supported by strong demand for our leading-edge process technologies. Moving into fourth quarter 2026, we expect our business to be supported by continued strong demand for our leading-edge process technologies, including the steep ramp-up of our 2-nanometer technology.
Where the schedule, the pricing power and the funding risk actually sit
- October's $17.88B already funds the fourth-quarter guide, so the near-term case is schedule confirmation rather than a raised bar.
- leaves 2027 guidance-free until the January results, so the multiple has to price a production plan rather than a demand curve.
- Gross margin of 66.4% falls to a 66% guide midpoint as 2nm dilution and a 3–4 point overseas mix penalty land.
- locks in 2027 pricing, with the vast majority of calendar 2027 HBM bit supply contracted at significantly higher prices.
- FQ4-26 revenue of $54.23B at an 86.8% gross margin, with fiscal first-quarter revenue guided to $61.5B at roughly 86%.
- Over one to three years the risk is supply, not demand: industry DRAM bits still grow in the low-20s% in 2027 and 2028 with no line of sight to balance.
- converts HBM4 into the mainstream product in 4Q26, with HBM4 set to pass HBM3E in both volume and revenue.
- Long-term agreements with 14 customers cover more than half of 2027 and 2028 capacity, so next year's revenue is largely pre-sold.
- A KRW 104.6tn quarter at roughly an 80% operating margin is the highest pricing power in the chain — and the most cyclical.
- converts DRAM and packaging capex into revenue, with DRAM now 26% of systems mix, up from 22%.
- Fiscal third-quarter revenue of $9.12B grew 25% at a 50.3% gross margin, with fourth-quarter guidance of $10.25B.
- Over one to three years, TSMC's $60–64B 2026 capex and ASML's 2028 capacity build keep tool demand funded by fabs rather than by customers' credit.
- sells into a shortfall it cannot fill, with supply for 2027 and 2028 already short of demand.
- Third-quarter net sales of €11.7B at a 57.5% gross margin, with full-year 2026 guided to €44–45B.
- Over one to three years, the 2028 capacity add being raised beyond the communicated 30% is the single biggest upside lever.
- pays for the chain: $75.7B of capex in twelve months against $46.9B of operating cash flow.
- Interest expense of $1.43B in the September quarter rose 55% year on year while revenue grew 30%.
- The $664B backlog is real, but each new contract adds funding rather than relief, and management is raising still more capital.
- funds $20.6B of capex with $16.8B of new debt while operating cash flow covers only $6.9B.
- Trailing interest expense of $1.87B equals 25% of trailing revenue, and the June quarter produced a $49M operating loss.
- Over the next two quarters the risk is refinancing a debt stack that compounds faster than contracted revenue.
- funds OpenAI with bonds: the third $10B tranche was paid with foreign-currency senior notes issued Sep 24, 2026.
- Cumulative OpenAI investment of $64.6B for about 13% now sits behind a repaid $40B bridge facility.
- Watch the reported round of up to $30B at a $1.25tn pre-money valuation (reported Oct 22, 2026); a mark-up there is the cleanest re-rating catalyst.
